LUCD NASDAQ
Lucid Diagnostics Inc.
1W: -24.1%
1M: -36.6%
3M: -41.9%
YTD: -44.0%
1Y: -38.5%
3Y: -57.3%
$0.63
-0.01 (-1.18%)
Weekly Expected Move ±11.8%
$0
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (46)
3 Key Reasons to Buy This Huge Turnaround Story That's Gaining Traction
BlackRock Inc. Buys New Position in Lucid Diagnostics Inc. $LUCD
Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives $4.19 Average PT from Brokerages
Lucid Diagnostics (LUCD) Q2 2026 Earnings Call Transcript
Lucid Diagnostics Inc. Q2 2026 Earnings Call Summary
Lucid Diagnostics Inc. (LUCD) Reports Q2 Loss, Lags Revenue Estimates
Neuronetics (STIM) Reports Q2 Loss, Beats Revenue Estimates
Pulse Biosciences, Inc (PLSE) Reports Q2 Loss, Misses Revenue Estimates
FocalTherics (FOCL) Surges 6.2%: Is This an Indication of Further Gains?
Alphatec (ATEC) Q2 Earnings Lag Estimates
Analysts Set Lucid Diagnostics Inc. (NASDAQ:LUCD) PT at $4.19
Globus Medical (GMED) Surges 5.1%: Is This an Indication of Further Gains?
Lucid Diagnostics Misses On Revenue, But 2026 Growth Outlook Lights Up Bull Case
Why Lucid Diagnostics Inc. (LUCD) Faced a Price Target Reduction After Q1 Results
PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results
Lucid Diagnostics Inc. Q1 2026 Earnings Call Summary
LUCD Q1 2026 Earnings Transcript
Lucid Diagnostics Inc. (LUCD) Reports Q1 Loss, Misses Revenue Estimates
Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results
Hyperfine, Inc. (HYPR) Reports Q1 Loss, Beats Revenue Estimates
Lucid Diagnostics Inc. (LUCD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
10x Genomics (TXG) Reports Q1 Loss, Beats Revenue Estimates
LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates
Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock
Lucid Diagnostics announces $18M offering of common stock
Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives Average Recommendation of “Moderate Buy” from Analysts
Texas Instruments To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Thursday
Lucid Diagnostics Inc. $LUCD Shares Purchased by Aberdeen Group plc
PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives $3.94 Consensus PT from Brokerages
Lucid Diagnostics signals expanded VA market access and 29% sequential test volume growth while targeting Medicare and commercial payer wins
Lucid Diagnostics (LUCD) Earnings Transcript
Lucid Diagnostics Inc. (LUCD) Reports Q4 Loss, Beats Revenue Estimates
Lucid Diagnostics Non-GAAP EPS of -$0.10 misses by $0.02, revenue of $1.5M beats by $0.11M
Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Earnings Scheduled For March 26, 2026
DarioHealth Corp. (DRIO) Reports Q4 Loss, Beats Revenue Estimates
ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Tops Revenue Estimates
Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026
12 Health Care Stocks Moving In Friday's After-Market Session
908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates
PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard®
Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection
Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree
Lucid Diagnostics Inc. (NASDAQ:LUCD) Given Average Recommendation of “Moderate Buy” by Brokerages